The Market Reports

Index

1 Dermal Fillers and Botulinum Toxin Market Overview
1.1 Product Overview and Scope of Dermal Fillers and Botulinum Toxin
1.2 Dermal Fillers and Botulinum Toxin Segment by Type
1.2.1 Global Dermal Fillers and Botulinum Toxin Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Dermal Fillers
1.2.3 Botulinum Toxin
1.3 Dermal Fillers and Botulinum Toxin Segment by Application
1.3.1 Global Dermal Fillers and Botulinum Toxin Sales Comparison by Application: (2021-2027)
1.3.2 Medical
1.3.3 Cosmetic
1.4 Global Dermal Fillers and Botulinum Toxin Market Size Estimates and Forecasts
1.4.1 Global Dermal Fillers and Botulinum Toxin Revenue 2016-2027
1.4.2 Global Dermal Fillers and Botulinum Toxin Sales 2016-2027
1.4.3 Dermal Fillers and Botulinum Toxin Market Size by Region: 2016 Versus 2021 Versus 2027

2 Dermal Fillers and Botulinum Toxin Market Competition by Manufacturers
2.1 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Manufacturers (2016-2021)
2.2 Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Dermal Fillers and Botulinum Toxin Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Dermal Fillers and Botulinum Toxin Manufacturing Sites, Area Served, Product Type
2.5 Dermal Fillers and Botulinum Toxin Market Competitive Situation and Trends
2.5.1 Dermal Fillers and Botulinum Toxin Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Dermal Fillers and Botulinum Toxin Players Market Share by Revenue
2.5.3 Global Dermal Fillers and Botulinum Toxin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Dermal Fillers and Botulinum Toxin Retrospective Market Scenario by Region
3.1 Global Dermal Fillers and Botulinum Toxin Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Dermal Fillers and Botulinum Toxin Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Dermal Fillers and Botulinum Toxin Market Facts & Figures by Country
3.3.1 North America Dermal Fillers and Botulinum Toxin Sales by Country
3.3.2 North America Dermal Fillers and Botulinum Toxin Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Dermal Fillers and Botulinum Toxin Market Facts & Figures by Country
3.4.1 Europe Dermal Fillers and Botulinum Toxin Sales by Country
3.4.2 Europe Dermal Fillers and Botulinum Toxin Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Dermal Fillers and Botulinum Toxin Market Facts & Figures by Region
3.5.1 Asia Pacific Dermal Fillers and Botulinum Toxin Sales by Region
3.5.2 Asia Pacific Dermal Fillers and Botulinum Toxin Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Dermal Fillers and Botulinum Toxin Market Facts & Figures by Country
3.6.1 Latin America Dermal Fillers and Botulinum Toxin Sales by Country
3.6.2 Latin America Dermal Fillers and Botulinum Toxin Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Dermal Fillers and Botulinum Toxin Market Facts & Figures by Country
3.7.1 Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Country
3.7.2 Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Dermal Fillers and Botulinum Toxin Historic Market Analysis by Type
4.1 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2016-2021)
4.2 Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Type (2016-2021)
4.3 Global Dermal Fillers and Botulinum Toxin Price by Type (2016-2021)

5 Global Dermal Fillers and Botulinum Toxin Historic Market Analysis by Application
5.1 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2016-2021)
5.2 Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Application (2016-2021)
5.3 Global Dermal Fillers and Botulinum Toxin Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Allergan Dermal Fillers and Botulinum Toxin Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Galderma
6.2.1 Galderma Corporation Information
6.2.2 Galderma Description and Business Overview
6.2.3 Galderma Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Galderma Dermal Fillers and Botulinum Toxin Product Portfolio
6.2.5 Galderma Recent Developments/Updates
6.3 LG Life Science
6.3.1 LG Life Science Corporation Information
6.3.2 LG Life Science Description and Business Overview
6.3.3 LG Life Science Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
6.3.4 LG Life Science Dermal Fillers and Botulinum Toxin Product Portfolio
6.3.5 LG Life Science Recent Developments/Updates
6.4 Merz
6.4.1 Merz Corporation Information
6.4.2 Merz Description and Business Overview
6.4.3 Merz Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Merz Dermal Fillers and Botulinum Toxin Product Portfolio
6.4.5 Merz Recent Developments/Updates
6.5 Medytox
6.5.1 Medytox Corporation Information
6.5.2 Medytox Description and Business Overview
6.5.3 Medytox Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Medytox Dermal Fillers and Botulinum Toxin Product Portfolio
6.5.5 Medytox Recent Developments/Updates
6.6 Bloomage
6.6.1 Bloomage Corporation Information
6.6.2 Bloomage Description and Business Overview
6.6.3 Bloomage Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Bloomage Dermal Fillers and Botulinum Toxin Product Portfolio
6.6.5 Bloomage Recent Developments/Updates
6.7 Bohus BioTech
6.6.1 Bohus BioTech Corporation Information
6.6.2 Bohus BioTech Description and Business Overview
6.6.3 Bohus BioTech Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Bohus BioTech Dermal Fillers and Botulinum Toxin Product Portfolio
6.7.5 Bohus BioTech Recent Developments/Updates
6.8 Sinclair Pharma
6.8.1 Sinclair Pharma Corporation Information
6.8.2 Sinclair Pharma Description and Business Overview
6.8.3 Sinclair Pharma Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Sinclair Pharma Dermal Fillers and Botulinum Toxin Product Portfolio
6.8.5 Sinclair Pharma Recent Developments/Updates
6.9 IMEIK
6.9.1 IMEIK Corporation Information
6.9.2 IMEIK Description and Business Overview
6.9.3 IMEIK Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
6.9.4 IMEIK Dermal Fillers and Botulinum Toxin Product Portfolio
6.9.5 IMEIK Recent Developments/Updates
6.10 Suneva Medical
6.10.1 Suneva Medical Corporation Information
6.10.2 Suneva Medical Description and Business Overview
6.10.3 Suneva Medical Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Suneva Medical Dermal Fillers and Botulinum Toxin Product Portfolio
6.10.5 Suneva Medical Recent Developments/Updates
6.11 Teoxane
6.11.1 Teoxane Corporation Information
6.11.2 Teoxane Dermal Fillers and Botulinum Toxin Description and Business Overview
6.11.3 Teoxane Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Teoxane Dermal Fillers and Botulinum Toxin Product Portfolio
6.11.5 Teoxane Recent Developments/Updates
6.12 Luminera
6.12.1 Luminera Corporation Information
6.12.2 Luminera Dermal Fillers and Botulinum Toxin Description and Business Overview
6.12.3 Luminera Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Luminera Dermal Fillers and Botulinum Toxin Product Portfolio
6.12.5 Luminera Recent Developments/Updates
6.13 SciVision Biotech
6.13.1 SciVision Biotech Corporation Information
6.13.2 SciVision Biotech Dermal Fillers and Botulinum Toxin Description and Business Overview
6.13.3 SciVision Biotech Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
6.13.4 SciVision Biotech Dermal Fillers and Botulinum Toxin Product Portfolio
6.13.5 SciVision Biotech Recent Developments/Updates
6.14 Haohai Bio
6.14.1 Haohai Bio Corporation Information
6.14.2 Haohai Bio Dermal Fillers and Botulinum Toxin Description and Business Overview
6.14.3 Haohai Bio Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Haohai Bio Dermal Fillers and Botulinum Toxin Product Portfolio
6.14.5 Haohai Bio Recent Developments/Updates
6.15 Ipsen
6.15.1 Ipsen Corporation Information
6.15.2 Ipsen Dermal Fillers and Botulinum Toxin Description and Business Overview
6.15.3 Ipsen Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Ipsen Dermal Fillers and Botulinum Toxin Product Portfolio
6.15.5 Ipsen Recent Developments/Updates
6.16 LIBP
6.16.1 LIBP Corporation Information
6.16.2 LIBP Dermal Fillers and Botulinum Toxin Description and Business Overview
6.16.3 LIBP Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
6.16.4 LIBP Dermal Fillers and Botulinum Toxin Product Portfolio
6.16.5 LIBP Recent Developments/Updates
6.17 US World Meds
6.17.1 US World Meds Corporation Information
6.17.2 US World Meds Dermal Fillers and Botulinum Toxin Description and Business Overview
6.17.3 US World Meds Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
6.17.4 US World Meds Dermal Fillers and Botulinum Toxin Product Portfolio
6.17.5 US World Meds Recent Developments/Updates
6.18 Hugel
6.18.1 Hugel Corporation Information
6.18.2 Hugel Dermal Fillers and Botulinum Toxin Description and Business Overview
6.18.3 Hugel Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Hugel Dermal Fillers and Botulinum Toxin Product Portfolio
6.18.5 Hugel Recent Developments/Updates
6.19 Daewoong
6.19.1 Daewoong Corporation Information
6.19.2 Daewoong Dermal Fillers and Botulinum Toxin Description and Business Overview
6.19.3 Daewoong Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Daewoong Dermal Fillers and Botulinum Toxin Product Portfolio
6.19.5 Daewoong Recent Developments/Updates

7 Dermal Fillers and Botulinum Toxin Manufacturing Cost Analysis
7.1 Dermal Fillers and Botulinum Toxin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Dermal Fillers and Botulinum Toxin
7.4 Dermal Fillers and Botulinum Toxin Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Dermal Fillers and Botulinum Toxin Distributors List
8.3 Dermal Fillers and Botulinum Toxin Customers

9 Dermal Fillers and Botulinum Toxin Market Dynamics
9.1 Dermal Fillers and Botulinum Toxin Industry Trends
9.2 Dermal Fillers and Botulinum Toxin Growth Drivers
9.3 Dermal Fillers and Botulinum Toxin Market Challenges
9.4 Dermal Fillers and Botulinum Toxin Market Restraints

10 Global Market Forecast
10.1 Dermal Fillers and Botulinum Toxin Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Dermal Fillers and Botulinum Toxin by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Dermal Fillers and Botulinum Toxin by Type (2022-2027)
10.2 Dermal Fillers and Botulinum Toxin Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Dermal Fillers and Botulinum Toxin by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Dermal Fillers and Botulinum Toxin by Application (2022-2027)
10.3 Dermal Fillers and Botulinum Toxin Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Dermal Fillers and Botulinum Toxin by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Dermal Fillers and Botulinum Toxin by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Dermal Fillers and Botulinum Toxin Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Dermal Fillers and Botulinum Toxin Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Dermal Fillers and Botulinum Toxin Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Dermal Fillers and Botulinum Toxin Covered in This Study
Table 5. Global Dermal Fillers and Botulinum Toxin Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Dermal Fillers and Botulinum Toxin Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Dermal Fillers and Botulinum Toxin Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Dermal Fillers and Botulinum Toxin Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Dermal Fillers and Botulinum Toxin Manufacturing Sites and Area Served
Table 11. Manufacturers Dermal Fillers and Botulinum Toxin Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Dermal Fillers and Botulinum Toxin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermal Fillers and Botulinum Toxin as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Dermal Fillers and Botulinum Toxin Sales by Region (2016-2021) & (K Units)
Table 16. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Region (2016-2021)
Table 17. Global Dermal Fillers and Botulinum Toxin Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Dermal Fillers and Botulinum Toxin Sales by Country (2016-2021) & (K Units)
Table 19. North America Dermal Fillers and Botulinum Toxin Sales Market Share by Country (2016-2021)
Table 20. North America Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Dermal Fillers and Botulinum Toxin Revenue Market Share by Country (2016-2021)
Table 22. Europe Dermal Fillers and Botulinum Toxin Sales by Country (2016-2021) & (K Units)
Table 23. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Country (2016-2021)
Table 24. Europe Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Dermal Fillers and Botulinum Toxin Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Dermal Fillers and Botulinum Toxin Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Dermal Fillers and Botulinum Toxin Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Dermal Fillers and Botulinum Toxin Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Dermal Fillers and Botulinum Toxin Revenue Market Share by Region (2016-2021)
Table 30. Latin America Dermal Fillers and Botulinum Toxin Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Dermal Fillers and Botulinum Toxin Sales Market Share by Country (2016-2021)
Table 32. Latin America Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Dermal Fillers and Botulinum Toxin Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Dermal Fillers and Botulinum Toxin Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue Market Share by Country (2016-2021)
Table 38. Global Dermal Fillers and Botulinum Toxin Sales (K Units) by Type (2016-2021)
Table 39. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2016-2021)
Table 40. Global Dermal Fillers and Botulinum Toxin Revenue (Million US$) by Type (2016-2021)
Table 41. Global Dermal Fillers and Botulinum Toxin Revenue Share by Type (2016-2021)
Table 42. Global Dermal Fillers and Botulinum Toxin Price (US$/Unit) by Type (2016-2021)
Table 43. Global Dermal Fillers and Botulinum Toxin Sales (K Units) by Application (2016-2021)
Table 44. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2016-2021)
Table 45. Global Dermal Fillers and Botulinum Toxin Revenue (Million US$) by Application (2016-2021)
Table 46. Global Dermal Fillers and Botulinum Toxin Revenue Share by Application (2016-2021)
Table 47. Global Dermal Fillers and Botulinum Toxin Price (US$/Unit) by Application (2016-2021)
Table 48. Allergan Corporation Information
Table 49. Allergan Description and Business Overview
Table 50. Allergan Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Allergan Dermal Fillers and Botulinum Toxin Product
Table 52. Allergan Recent Developments/Updates
Table 53. Galderma Corporation Information
Table 54. Galderma Description and Business Overview
Table 55. Galderma Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Galderma Dermal Fillers and Botulinum Toxin Product
Table 57. Galderma Recent Developments/Updates
Table 58. LG Life Science Corporation Information
Table 59. LG Life Science Description and Business Overview
Table 60. LG Life Science Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. LG Life Science Dermal Fillers and Botulinum Toxin Product
Table 62. LG Life Science Recent Developments/Updates
Table 63. Merz Corporation Information
Table 64. Merz Description and Business Overview
Table 65. Merz Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Merz Dermal Fillers and Botulinum Toxin Product
Table 67. Merz Recent Developments/Updates
Table 68. Medytox Corporation Information
Table 69. Medytox Description and Business Overview
Table 70. Medytox Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Medytox Dermal Fillers and Botulinum Toxin Product
Table 72. Medytox Recent Developments/Updates
Table 73. Bloomage Corporation Information
Table 74. Bloomage Description and Business Overview
Table 75. Bloomage Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Bloomage Dermal Fillers and Botulinum Toxin Product
Table 77. Bloomage Recent Developments/Updates
Table 78. Bohus BioTech Corporation Information
Table 79. Bohus BioTech Description and Business Overview
Table 80. Bohus BioTech Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Bohus BioTech Dermal Fillers and Botulinum Toxin Product
Table 82. Bohus BioTech Recent Developments/Updates
Table 83. Sinclair Pharma Corporation Information
Table 84. Sinclair Pharma Description and Business Overview
Table 85. Sinclair Pharma Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Sinclair Pharma Dermal Fillers and Botulinum Toxin Product
Table 87. Sinclair Pharma Recent Developments/Updates
Table 88. IMEIK Corporation Information
Table 89. IMEIK Description and Business Overview
Table 90. IMEIK Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. IMEIK Dermal Fillers and Botulinum Toxin Product
Table 92. IMEIK Recent Developments/Updates
Table 93. Suneva Medical Corporation Information
Table 94. Suneva Medical Description and Business Overview
Table 95. Suneva Medical Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Suneva Medical Dermal Fillers and Botulinum Toxin Product
Table 97. Suneva Medical Recent Developments/Updates
Table 98. Teoxane Corporation Information
Table 99. Teoxane Description and Business Overview
Table 100. Teoxane Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Teoxane Dermal Fillers and Botulinum Toxin Product
Table 102. Teoxane Recent Developments/Updates
Table 103. Luminera Corporation Information
Table 104. Luminera Description and Business Overview
Table 105. Luminera Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Luminera Dermal Fillers and Botulinum Toxin Product
Table 107. Luminera Recent Developments/Updates
Table 108. SciVision Biotech Corporation Information
Table 109. SciVision Biotech Description and Business Overview
Table 110. SciVision Biotech Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. SciVision Biotech Dermal Fillers and Botulinum Toxin Product
Table 112. SciVision Biotech Recent Developments/Updates
Table 113. Haohai Bio Corporation Information
Table 114. Haohai Bio Description and Business Overview
Table 115. Haohai Bio Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Haohai Bio Dermal Fillers and Botulinum Toxin Product
Table 117. Haohai Bio Recent Developments/Updates
Table 118. Ipsen Corporation Information
Table 119. Ipsen Description and Business Overview
Table 120. Ipsen Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Ipsen Dermal Fillers and Botulinum Toxin Product
Table 122. Ipsen Recent Developments/Updates
Table 123. LIBP Corporation Information
Table 124. LIBP Description and Business Overview
Table 125. LIBP Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. LIBP Dermal Fillers and Botulinum Toxin Product
Table 127. LIBP Recent Developments/Updates
Table 128. US World Meds Corporation Information
Table 129. US World Meds Description and Business Overview
Table 130. US World Meds Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. US World Meds Dermal Fillers and Botulinum Toxin Product
Table 132. US World Meds Recent Developments/Updates
Table 133. Hugel Corporation Information
Table 134. Hugel Description and Business Overview
Table 135. Hugel Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. Hugel Dermal Fillers and Botulinum Toxin Product
Table 137. Hugel Recent Developments/Updates
Table 138. Daewoong Corporation Information
Table 139. Daewoong Description and Business Overview
Table 140. Daewoong Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 141. Daewoong Dermal Fillers and Botulinum Toxin Product
Table 142. Daewoong Recent Developments/Updates
Table 143. Production Base and Market Concentration Rate of Raw Material
Table 144. Key Suppliers of Raw Materials
Table 145. Dermal Fillers and Botulinum Toxin Distributors List
Table 146. Dermal Fillers and Botulinum Toxin Customers List
Table 147. Dermal Fillers and Botulinum Toxin Market Trends
Table 148. Dermal Fillers and Botulinum Toxin Growth Drivers
Table 149. Dermal Fillers and Botulinum Toxin Market Challenges
Table 150. Dermal Fillers and Botulinum Toxin Market Restraints
Table 151. Global Dermal Fillers and Botulinum Toxin Sales Forecast by Type (2022-2027) & (K Units)
Table 152. Global Dermal Fillers and Botulinum Toxin Sales Market Share Forecast by Type (2022-2027)
Table 153. Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 154. Global Dermal Fillers and Botulinum Toxin Revenue Market Share Forecast by Type (2022-2027)
Table 155. Global Dermal Fillers and Botulinum Toxin Sales Forecast by Application (2022-2027) & (K Units)
Table 156. Global Dermal Fillers and Botulinum Toxin Sales Market Share Forecast by Application (2022-2027)
Table 157. Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 158. Global Dermal Fillers and Botulinum Toxin Revenue Market Share Forecast by Application (2022-2027)
Table 159. Global Dermal Fillers and Botulinum Toxin Sales Forecast by Region (2022-2027) & (K Units)
Table 160. Global Dermal Fillers and Botulinum Toxin Sales Market Share Forecast by Region (2022-2027)
Table 161. Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 162. Global Dermal Fillers and Botulinum Toxin Revenue Market Share Forecast by Region (2022-2027)
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Dermal Fillers and Botulinum Toxin
Figure 2. Global Dermal Fillers and Botulinum Toxin Market Share by Type in 2020 & 2027
Figure 3. Dermal Fillers Product Picture
Figure 4. Botulinum Toxin Product Picture
Figure 5. Global Dermal Fillers and Botulinum Toxin Market Share by Application in 2020 & 2027
Figure 6. Medical
Figure 7. Cosmetic
Figure 8. Global Dermal Fillers and Botulinum Toxin Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Dermal Fillers and Botulinum Toxin Market Size 2016-2027 (US$ Million)
Figure 10. Global Dermal Fillers and Botulinum Toxin Sales 2016-2027 (K Units)
Figure 11. Global Dermal Fillers and Botulinum Toxin Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Dermal Fillers and Botulinum Toxin Sales Share by Manufacturers in 2020
Figure 13. Global Dermal Fillers and Botulinum Toxin Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Dermal Fillers and Botulinum Toxin Players: Market Share by Revenue in 2020
Figure 15. Dermal Fillers and Botulinum Toxin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Region (2016-2021)
Figure 17. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Region in 2020
Figure 18. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Region (2016-2021)
Figure 19. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Region in 2020
Figure 20. U.S. Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Dermal Fillers and Botulinum Toxin by Type (2016-2021)
Figure 45. Sales Market Share of Dermal Fillers and Botulinum Toxin by Application (2016-2021)
Figure 46. Sales Market Share of Dermal Fillers and Botulinum Toxin by Application in 2020
Figure 47. Revenue Share of Dermal Fillers and Botulinum Toxin by Application (2016-2021)
Figure 48. Revenue Share of Dermal Fillers and Botulinum Toxin by Application in 2020
Figure 49. Manufacturing Cost Structure of Dermal Fillers and Botulinum Toxin
Figure 50. Manufacturing Process Analysis of Dermal Fillers and Botulinum Toxin
Figure 51. Dermal Fillers and Botulinum Toxin Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed